Washington | Scientists have discovered natural triggers that could reduce the chance of life-threatening, congenital heart defects among newborns.
Those triggers can override developmental, biological miscues, leading to proper embryonic heart and valve formation, researchers said. The heart is the first organ to form in the embryo.
It morphs dynamically and rapidly all the while pumping nutrients to the developing body, said senior author Jonathan Butcher, associate professor at Cornell University in US.
The early embryonic heart originates as a looped tube, without valves or pumping chambers. During the last few weeks of the first trimester, these heart chambers form, but need something to maintain one-way blood flow.
Wispy globular masses (called cushions because of their shape in the heart wall) need to condense and elongate to form thin robust leaflets capable of fast and resilient opening and closing, Butcher said.
It is this maturation process that’s likely disrupted in many clinical cases, he said. Until this study, scientists did not know how mechanical forces drove the biological remodelling of cushions into valves.
Scientists understood that the embryonic heart needed blood flow to grow, but the valve component’s role was not entirely understood, Butcher said.
The researchers found that cyclic stretches and stressing forces activate sensitive enzymes called GTPases, specifically RhoA and Rac1, which coordinate the embryonic heart’s maturation.
Without the enzymes activating at the proper times, heart valves do not form correctly. We identified a mechanism that transduced – or translated – a mechanical force into a biological response, Butcher said.
That biological response over time creates these thin, flexible, formative leaflets. If this tissue fails to get thinner, that’s a problem. If the tissue fails to elongate, that’s a problem, he said.
The findings lay a foundation for hemodynamically informed surgical interventions to potentially retard valve malformation – or to restore it, Butcher said.
Subscribe to our email newsletter.